Cipla submits application with USFDA for generic version of asthma drug

Drug major Cipla on Monday said it has submitted an application with
the US health regulator for a generic version of GSK's Advair Diskus,
which is used in the treatment of asthma and other respiratory
disorders.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/cipla-submits-application-with-usfda-for-generic-version-of-asthma-drug/articleshow/75798947.cms

Comments

Popular posts from this blog

Clinical Database Management Professional Vacancy @ Teva

Pharma Production Executive Post Vacancy @ Intas

Biotecnika Times – Newsletter 28.02.2020 – DST Women Scientist WOS B, DBT-IOC Recruitment